127 related articles for article (PubMed ID: 37742362)
1. Design, optimization, in vitro and in vivo evaluation of triamcinolone acetonide nanocrystals loaded in situ gel for topical ocular delivery.
Khan MS; Ravi PR; Dhavan DS
Colloids Surf B Biointerfaces; 2023 Nov; 231():113539. PubMed ID: 37742362
[TBL] [Abstract][Full Text] [Related]
2. Design, optimization and pharmacokinetic evaluation of PLGA phosphatidylcholine hybrid nanoparticles of triamcinolone acetonide loaded in situ gel for topical ocular delivery.
Shareef Khan M; Rao Ravi P; Shrikant Dhavan D
Int J Pharm; 2023 Nov; 647():123530. PubMed ID: 37858638
[TBL] [Abstract][Full Text] [Related]
3. Dose identification of triamcinolone acetonide for noninvasive pre-corneal administration in the treatment of posterior uveitis using a rapid, sensitive HPLC method with photodiode-array detector.
Khan MS; Ravi PR; Mullapudi TVR
Biomed Chromatogr; 2022 Feb; 36(2):e5264. PubMed ID: 34653273
[TBL] [Abstract][Full Text] [Related]
4. Optimization and in vivo evaluation of triamcinolone acetonide loaded in situ gel prepared using reacted tamarind seed xyloglucan and kappa-carrageenan for ocular delivery.
Khan MS; Ravi PR; Mir SI; Rawat PS
Int J Biol Macromol; 2023 Apr; 233():123533. PubMed ID: 36740111
[TBL] [Abstract][Full Text] [Related]
5. In Situ Gel of Triamcinolone Acetonide-Loaded Solid Lipid Nanoparticles for Improved Topical Ocular Delivery: Tear Kinetics and Ocular Disposition Studies.
Tatke A; Dudhipala N; Janga KY; Balguri SP; Avula B; Jablonski MM; Majumdar S
Nanomaterials (Basel); 2018 Dec; 9(1):. PubMed ID: 30591688
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the carbopol gel of solid lipid nanoparticles for the transdermal iontophoretic delivery of triamcinolone acetonide acetate.
Liu W; Hu M; Liu W; Xue C; Xu H; Yang X
Int J Pharm; 2008 Nov; 364(1):135-41. PubMed ID: 18778760
[TBL] [Abstract][Full Text] [Related]
7. Development of a dry powder inhaler, the Ultrahaler, containing triamcinolone acetonide using in vitro-in vivo relationships.
Lim JG; Shah B; Rohatagi S; Bell A
Am J Ther; 2006; 13(1):32-42. PubMed ID: 16428920
[TBL] [Abstract][Full Text] [Related]
8. Improved anti-inflammatory effects in rabbit eye model using biodegradable poly beta-amino ester nanoparticles of triamcinolone acetonide.
Sabzevari A; Adibkia K; Hashemi H; De Geest BG; Mohsenzadeh N; Atyabi F; Ghahremani MH; Khoshayand MR; Dinarvand R
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5520-6. PubMed ID: 23833065
[TBL] [Abstract][Full Text] [Related]
9. Design and evaluation of rufinamide nanocrystals loaded thermoresponsive nasal
Dalvi A; Ravi PR; Uppuluri CT
Front Pharmacol; 2022; 13():943772. PubMed ID: 36267292
[TBL] [Abstract][Full Text] [Related]
10. Application of co-grinding to formulate a model pMDI suspension.
Williams RO; Repka MA; Barron MK
Eur J Pharm Biopharm; 1999 Sep; 48(2):131-40. PubMed ID: 10469931
[TBL] [Abstract][Full Text] [Related]
11. Design, Characterization and Pharmacokinetic-Pharmacodynamic Evaluation of Poloxamer and Kappa-Carrageenan-Based Dual-Responsive In Situ Gel of Nebivolol for Treatment of Open-Angle Glaucoma.
Rawat PS; Ravi PR; Mir SI; Khan MS; Kathuria H; Katnapally P; Bhatnagar U
Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839727
[TBL] [Abstract][Full Text] [Related]
12. Superiority of TPGS-loaded micelles in the brain delivery of vinpocetine via administration of thermosensitive intranasal gel.
Ahmed TA; El-Say KM; Ahmed OA; Aljaeid BM
Int J Nanomedicine; 2019; 14():5555-5567. PubMed ID: 31413562
[No Abstract] [Full Text] [Related]
13. In Situ Gelling Systems Using Pluronic F127 Enhance Corneal Permeability of Indomethacin Nanocrystals.
Nagai N; Isaka T; Deguchi S; Minami M; Yamaguchi M; Otake H; Okamoto N; Nakazawa Y
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992931
[TBL] [Abstract][Full Text] [Related]
14. Development of Triamcinolone Acetonide Nanocrystals for Ocular Administration.
Formica ML; Awde Alfonso HG; Paredes AJ; Melian ME; Camacho NM; Faccio R; Tártara LI; Palma SD
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36840006
[TBL] [Abstract][Full Text] [Related]
15. Topical instillation of triamcinolone acetonide-loaded emulsomes for posterior ocular delivery: statistical optimization and in vitro-in vivo studies.
Kapadia R; Parikh K; Jain M; Sawant K
Drug Deliv Transl Res; 2021 Jun; 11(3):984-999. PubMed ID: 32567039
[TBL] [Abstract][Full Text] [Related]
16. Triamcinolone acetonide loaded-cationic nano-lipoidal formulation for uveitis: Evidences of improved biopharmaceutical performance and anti-inflammatory activity.
Nirbhavane P; Sharma G; Singh B; Begum G; Jones MC; Rauz S; Vincent R; Denniston AK; Hill LJ; Katare OP
Colloids Surf B Biointerfaces; 2020 Jun; 190():110902. PubMed ID: 32143010
[TBL] [Abstract][Full Text] [Related]
17. Design and Optimization of Solid Lipid Nanoparticles Loaded with Triamcinolone Acetonide.
Talarico L; Pepi S; Susino S; Leone G; Bonechi C; Consumi M; Clemente I; Magnani A
Molecules; 2023 Jul; 28(15):. PubMed ID: 37570717
[TBL] [Abstract][Full Text] [Related]
18. Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model.
Chen M; Li X; Liu J; Han Y; Cheng L
J Control Release; 2015 Apr; 203():109-17. PubMed ID: 25700623
[TBL] [Abstract][Full Text] [Related]
19. Safety of intradiscal delivery of triamcinolone acetonide by a poly(esteramide) microsphere platform in a large animal model of intervertebral disc degeneration.
Rudnik-Jansen I; Tellegen A; Beukers M; Öner F; Woike N; Mihov G; Thies J; Meij B; Tryfonidou M; Creemers L
Spine J; 2019 May; 19(5):905-919. PubMed ID: 31056104
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of VEGF mRNA expression by triamcinolone acetonide acetate-loaded chitosan derivative nanoparticles in human retinal pigment epithelial cells.
Zhou H; Yang L; Li H; Gong H; Cheng L; Zheng H; Zhang LM; Lan Y
Int J Nanomedicine; 2012; 7():4649-60. PubMed ID: 22942646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
